+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer



Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer



Journal of Hematology and Oncology 2: 1



Curative surgery is not an option for many patients with clinical stage I non-small-cell lung carcinoma (NSCLC), but radical radiosurgery may be effective. Inoperable patients with small peripheral clinical stage I NSCLC were enrolled in this study. Three-to-five fiducial markers were implanted in or near tumors under CT guidance. Gross tumor volumes (GTVs) were contoured using lung windows. The GTV margin was expanded by 5 mm to establish the planning treatment volume (PTV). A dose of 42-60 Gy was delivered to the PTV in 3 equal fractions in less than 2 weeks using the CyberKnife radiosurgery system. The 30-Gy isodose contour extended at least 1 cm from the GTV. Physical examination, CT imaging and pulmonary function testing were completed at 6 months intervals for three years following treatment. Twenty patients with an average maximum tumor diameter of 2.2 cm (range, 1.1 - 3.5 cm) and a mean FEV1 of 1.08 liters (range, 0.53 - 1.71 L) were treated. Pneumothorax requiring tube thoracostomy occurred following CT-guided fiducial placement in 25% of the patients. All patients completed treatment with few acute side effects and no procedure-related mortality. Transient chest wall discomfort developed in 8 of the 12 patients with lesions within 5 mm of the pleura. The mean percentage of the total lung volume receiving a minimum of 15 Gy was 7.3% (range, 2.4% to 11.3%). One patient who received concurrent gefitinib developed short-lived, grade III radiation pneumonitis. The mean percent predicted DLCO decreased by 9% and 11% at 6 and 12 months, respectively. There were no local failures, regional lymph node recurrences or distant metastases. With a median follow-up of 25 months for the surviving patients, Kaplan-Meier overall survival estimate at 2 years was 87%, with deaths due to COPD progression. Radical CyberKnife radiosurgery is a well-tolerated treatment option for inoperable patients with small, peripheral stage I NSCLC. Effective doses and adequate margins are likely to have contributed to the optimal early local control seen in this study.

(PDF emailed within 0-6 h: $19.90)

Accession: 055345749

Download citation: RISBibTeXText

PMID: 19149899

DOI: 10.1186/1756-8722-2-1


Related references

Radiosurgery with real-time tumor motion tracking: An effective nonsurgical treatment alternative for small peripheral stage I non-small cell lung cancer. Chest 132(4): 459b-1-459b-2, 2007

CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer. Frontiers in Oncology 2: 9, 2012

CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. Journal of Hematology and Oncology 3: 6, 2010

Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy. Molecular and Clinical Oncology 3(2): 442-448, 2015

Treatment of stage I non-small cell lung cancer with CyberKnife, image-guided robotic stereotactic radiosurgery. Oncology Reports 21(3): 693-696, 2009

Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiation Oncology 2: 39, 2007

Robotic Radiosurgery for Inoperable Patients with Peripheral Stage IA Non-small Cell Lung Cancer: Local Control and Survival using 5-mm Margins. International Journal of Radiation Oncology*biology*physics 78(3): S815-S816, 2010

Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer. Radiation Oncology Journal 33(2): 89-97, 2015

P-711 CyberKnife frameless image-guided radiosurgery with the Synchrony motion tracking module in the definitive treatment of small peripheral lung tumors: The Georgetown University Hospital early experience. Lung Cancer 49: S305-S306, 2005

Successful treatment of non-small cell lung tumor with 15 lesions by CyberKnife radiosurgery: A case report. Experimental and Therapeutic Medicine 6(3): 808-810, 2013

102P: Ablative robotic radiosurgery for inoperable patients with stage IA-IB non small cell lung cancer. Journal of Thoracic Oncology 11(4 Suppl): S101-S101, 2016

Robotic Stereotactic Body Radiation Therapy (SBRT) With Fiducial Tracking for Inoperable Peripheral Stage I Non-Small Cell Lung Cancer (NSCLC): Four-Year Disease Control and Survival Outcomes. International Journal of Radiation Oncology*biology*physics 90(1): S610-S611, 2014

Preliminary effect of Cyberknife radiosurgery in the treatment of 31 patients with advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 14(4): 329-334, 2011

Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer. Medical Oncology 32(3): 55, 2016

Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer. Lung Cancer 77(3): 532-536, 2012